Gonadotropin-releasing hormone agonist versus expectant management for treating multiple leiomyomas after myomectomy: the study protocol for a multicentre, prospective, randomised controlled clinical trial
Open Access
- 18 October 2021
- Vol. 11 (10), e044347
- https://doi.org/10.1136/bmjopen-2020-044347
Abstract
Introduction Leiomyoma recurrence is a major concern for long-term myomectomy management, especially for multiple leiomyomas. Gonadotropin-releasing hormone agonist (GnRHa) is one of the most effective medications to reduce the volume of fibroids and the uterus. However, its role in preventing recurrence after conservative surgery remains unclear. At present, there is no randomised clinical trial determining the efficacy of GnRHa treatment for preventing multiple leiomyomas recurrence after myomectomy. Methods and analysis We are conducting a phase IV randomised controlled trial in women aged 18–45 undergoing myomectomy for multiple leiomyomas. After surgery, women whose pathological result confirms multiple leiomyomas are randomised in a 1:1 ratio into an observation or GnRHa group. The primary outcome is the recurrence of either clinical symptoms or fibroids on imaging. Patients will be assessed for adverse events during the follow-up. Ethics and dissemination The study was approved by the Medical Ethics Committee of the Tongji Hospital Affiliated with the Tongji Medical College of Huazhong University of Science and Technology (TJ-IRB20180311) according to the submitted study protocol (V.1.0, 10 November 2017) and informed consent (V.1.0, 10 November 2017). The results will be presented at domestic and international conferences and published in peer-reviewed journals. Trial registration number ChiCTR-IPR-17012992.This publication has 16 references indexed in Scilit:
- Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growthHuman Reproduction Update, 2015
- With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?Fertility and Sterility, 2014
- Long-term risk of fibroid recurrence after laparoscopic myomectomyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2014
- The Impact of Preoperative Gonadotropin-Releasing Hormone Agonist Treatment on Women With Uterine FibroidsObstetrical & Gynecological Survey, 2014
- Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissuesMolecular Human Reproduction, 2013
- The Genetic Bases of Uterine Fibroids; A Review2011
- ACOG Practice Bulletin No. 96: Alternatives to Hysterectomy in the Management of LeiomyomasObstetrics & Gynecology, 2008
- High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidenceAmerican Journal of Obstetrics and Gynecology, 2003
- What are the implications of myomas on fertility?Human Reproduction, 2002
- Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomyActa Obstetricia et Gynecologica Scandinavica, 2001